Autoimmune Disease Diagnostics Market 2027 By Type, Product, Technology and Geography | The Insight Partners

Autoimmune Disease Diagnostics Market to 2027 - Global Analysis and Forecasts By Type (Localized Autoimmune Disease Diagnostic, Systemic Autoimmune Disease Diagnostic); Product (Drugs, Therapeutic and Monitoring Equipment, Diagnostic Equipment); Technology (Bridge Therapy, Disease-modifying Antirheumatic Drugs (DMARD), Topical Therapy, Phototherapy, Helminthic Therapy, Recombinant Technology) and Geography

Report Code: TIPRE00004904 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
The immune system protects body from various bacterial, viral infections and from other diseases. The autoimmune disorder is abnormal immune response occurring in the body. Autoimmune diseases decreases body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease are more common women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are various tests commercially available at several healthcare centers to diagnose the autoimmune diseases.

MARKET DYNAMICS
The autoimmune disease diagnostics market is anticipated to grow due to factors such as increase in government funding, collaboration of clinics and diagnostics centers, rise in incidence of diseases such as rheumatoid arthritis, Graves and Hashimoto's thyroid disease, awareness about the various autoimmune diseases, the advancement in medical fields, improved laboratories techniques and others. However the developments in emerging market, advancement in novel biomarkers for prognosis of diseases are expected to provide the new opportunities in market growth.

MARKET SCOPE
The "Global Autoimmune Disease Diagnostics Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of autoimmune disease diagnostics market with detailed market segmentation by type, product, technology, and geography. The global autoimmune disease diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading autoimmune disease diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global autoimmune disease diagnostics market is segmented on the basis of type, product, and technology. Based on type, the market is segmented as localized autoimmune disease diagnostic, and systemic autoimmune disease diagnostic. Based on product the market is segmented as drugs, therapeutics and monitoring equipment, and diagnostic equipment. On the basis of technology, the autoimmune disease diagnostics market is segmented into bridge therapy, disease-modifying antirheumatic drugs (DMARD), topical therapy, phototherapy, helminthic therapy, and recombinant technology.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global autoimmune disease diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The autoimmune disease diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting autoimmune disease diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the autoimmune disease diagnostics market in these regions.

MARKET PLAYERS
The reports cover key developments in the autoimmune disease diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from autoimmune disease diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for autoimmune disease diagnostics in the global market. Below mentioned is the list of few companies engaged in the autoimmune disease diagnostics market.

The report also includes the profiles of key autoimmune disease diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • AstraZeneca
  • F. Hoffmann-La Roche
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Inova Diagnostics Inc.
  • Bio-Rad Laboratories Inc.
  • Hemagen Diagnostics Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Autoimmune Disease Diagnostics Market - By Type
1.3.2 Autoimmune Disease Diagnostics Market - By Product
1.3.3 Autoimmune Disease Diagnostics Market - By Technology
1.3.4 Autoimmune Disease Diagnostics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. AUTOIMMUNE DISEASE DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. AUTOIMMUNE DISEASE DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTIC
7.3.1. Overview
7.3.2. Localized Autoimmune Disease Diagnostic Market Forecast and Analysis
7.4. SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTIC
7.4.1. Overview
7.4.2. Systemic Autoimmune Disease Diagnostic Market Forecast and Analysis
8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. DRUGS
8.3.1. Overview
8.3.2. Drugs Market Forecast and Analysis
8.4. THERAPEUTIC AND MONITORING EQUIPMENT
8.4.1. Overview
8.4.2. Therapeutic and Monitoring Equipment Market Forecast and Analysis
8.5. DIAGNOSTIC EQUIPMENT
8.5.1. Overview
8.5.2. Diagnostic Equipment Market Forecast and Analysis
9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9.1. OVERVIEW
9.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
9.3. BRIDGE THERAPY
9.3.1. Overview
9.3.2. Bridge Therapy Market Forecast and Analysis
9.4. DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARD)
9.4.1. Overview
9.4.2. Disease-Modifying Antirheumatic Drugs (DMARD) Market Forecast and Analysis
9.5. TOPICAL THERAPY
9.5.1. Overview
9.5.2. Topical Therapy Market Forecast and Analysis
9.6. PHOTOTHERAPY
9.6.1. Overview
9.6.2. Phototherapy Market Forecast and Analysis
9.7. HELMINTHIC THERAPY
9.7.1. Overview
9.7.2. Helminthic Therapy Market Forecast and Analysis
9.8. RECOMBINANT TECHNOLOGY
9.8.1. Overview
9.8.2. Recombinant Technology Market Forecast and Analysis
10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Autoimmune Disease Diagnostics Market Overview
10.1.2 North America Autoimmune Disease Diagnostics Market Forecasts and Analysis
10.1.3 North America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Type
10.1.4 North America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Product
10.1.5 North America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Technology
10.1.6 North America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Autoimmune Disease Diagnostics Market
10.1.6.1.1 United States Autoimmune Disease Diagnostics Market by Type
10.1.6.1.2 United States Autoimmune Disease Diagnostics Market by Product
10.1.6.1.3 United States Autoimmune Disease Diagnostics Market by Technology
10.1.6.2 Canada Autoimmune Disease Diagnostics Market
10.1.6.2.1 Canada Autoimmune Disease Diagnostics Market by Type
10.1.6.2.2 Canada Autoimmune Disease Diagnostics Market by Product
10.1.6.2.3 Canada Autoimmune Disease Diagnostics Market by Technology
10.1.6.3 Mexico Autoimmune Disease Diagnostics Market
10.1.6.3.1 Mexico Autoimmune Disease Diagnostics Market by Type
10.1.6.3.2 Mexico Autoimmune Disease Diagnostics Market by Product
10.1.6.3.3 Mexico Autoimmune Disease Diagnostics Market by Technology
10.2. EUROPE
10.2.1 Europe Autoimmune Disease Diagnostics Market Overview
10.2.2 Europe Autoimmune Disease Diagnostics Market Forecasts and Analysis
10.2.3 Europe Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Type
10.2.4 Europe Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Product
10.2.5 Europe Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Technology
10.2.6 Europe Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Autoimmune Disease Diagnostics Market
10.2.6.1.1 Germany Autoimmune Disease Diagnostics Market by Type
10.2.6.1.2 Germany Autoimmune Disease Diagnostics Market by Product
10.2.6.1.3 Germany Autoimmune Disease Diagnostics Market by Technology
10.2.6.2 France Autoimmune Disease Diagnostics Market
10.2.6.2.1 France Autoimmune Disease Diagnostics Market by Type
10.2.6.2.2 France Autoimmune Disease Diagnostics Market by Product
10.2.6.2.3 France Autoimmune Disease Diagnostics Market by Technology
10.2.6.3 Italy Autoimmune Disease Diagnostics Market
10.2.6.3.1 Italy Autoimmune Disease Diagnostics Market by Type
10.2.6.3.2 Italy Autoimmune Disease Diagnostics Market by Product
10.2.6.3.3 Italy Autoimmune Disease Diagnostics Market by Technology
10.2.6.4 Spain Autoimmune Disease Diagnostics Market
10.2.6.4.1 Spain Autoimmune Disease Diagnostics Market by Type
10.2.6.4.2 Spain Autoimmune Disease Diagnostics Market by Product
10.2.6.4.3 Spain Autoimmune Disease Diagnostics Market by Technology
10.2.6.5 United Kingdom Autoimmune Disease Diagnostics Market
10.2.6.5.1 United Kingdom Autoimmune Disease Diagnostics Market by Type
10.2.6.5.2 United Kingdom Autoimmune Disease Diagnostics Market by Product
10.2.6.5.3 United Kingdom Autoimmune Disease Diagnostics Market by Technology
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Autoimmune Disease Diagnostics Market Overview
10.3.2 Asia-Pacific Autoimmune Disease Diagnostics Market Forecasts and Analysis
10.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Product
10.3.5 Asia-Pacific Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Technology
10.3.6 Asia-Pacific Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Autoimmune Disease Diagnostics Market
10.3.6.1.1 Australia Autoimmune Disease Diagnostics Market by Type
10.3.6.1.2 Australia Autoimmune Disease Diagnostics Market by Product
10.3.6.1.3 Australia Autoimmune Disease Diagnostics Market by Technology
10.3.6.2 China Autoimmune Disease Diagnostics Market
10.3.6.2.1 China Autoimmune Disease Diagnostics Market by Type
10.3.6.2.2 China Autoimmune Disease Diagnostics Market by Product
10.3.6.2.3 China Autoimmune Disease Diagnostics Market by Technology
10.3.6.3 India Autoimmune Disease Diagnostics Market
10.3.6.3.1 India Autoimmune Disease Diagnostics Market by Type
10.3.6.3.2 India Autoimmune Disease Diagnostics Market by Product
10.3.6.3.3 India Autoimmune Disease Diagnostics Market by Technology
10.3.6.4 Japan Autoimmune Disease Diagnostics Market
10.3.6.4.1 Japan Autoimmune Disease Diagnostics Market by Type
10.3.6.4.2 Japan Autoimmune Disease Diagnostics Market by Product
10.3.6.4.3 Japan Autoimmune Disease Diagnostics Market by Technology
10.3.6.5 South Korea Autoimmune Disease Diagnostics Market
10.3.6.5.1 South Korea Autoimmune Disease Diagnostics Market by Type
10.3.6.5.2 South Korea Autoimmune Disease Diagnostics Market by Product
10.3.6.5.3 South Korea Autoimmune Disease Diagnostics Market by Technology
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Autoimmune Disease Diagnostics Market Overview
10.4.2 Middle East and Africa Autoimmune Disease Diagnostics Market Forecasts and Analysis
10.4.3 Middle East and Africa Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Product
10.4.5 Middle East and Africa Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Technology
10.4.6 Middle East and Africa Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Autoimmune Disease Diagnostics Market
10.4.6.1.1 South Africa Autoimmune Disease Diagnostics Market by Type
10.4.6.1.2 South Africa Autoimmune Disease Diagnostics Market by Product
10.4.6.1.3 South Africa Autoimmune Disease Diagnostics Market by Technology
10.4.6.2 Saudi Arabia Autoimmune Disease Diagnostics Market
10.4.6.2.1 Saudi Arabia Autoimmune Disease Diagnostics Market by Type
10.4.6.2.2 Saudi Arabia Autoimmune Disease Diagnostics Market by Product
10.4.6.2.3 Saudi Arabia Autoimmune Disease Diagnostics Market by Technology
10.4.6.3 U.A.E Autoimmune Disease Diagnostics Market
10.4.6.3.1 U.A.E Autoimmune Disease Diagnostics Market by Type
10.4.6.3.2 U.A.E Autoimmune Disease Diagnostics Market by Product
10.4.6.3.3 U.A.E Autoimmune Disease Diagnostics Market by Technology
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Autoimmune Disease Diagnostics Market Overview
10.5.2 South and Central America Autoimmune Disease Diagnostics Market Forecasts and Analysis
10.5.3 South and Central America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Type
10.5.4 South and Central America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Product
10.5.5 South and Central America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Technology
10.5.6 South and Central America Autoimmune Disease Diagnostics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Autoimmune Disease Diagnostics Market
10.5.6.1.1 Brazil Autoimmune Disease Diagnostics Market by Type
10.5.6.1.2 Brazil Autoimmune Disease Diagnostics Market by Product
10.5.6.1.3 Brazil Autoimmune Disease Diagnostics Market by Technology
10.5.6.2 Argentina Autoimmune Disease Diagnostics Market
10.5.6.2.1 Argentina Autoimmune Disease Diagnostics Market by Type
10.5.6.2.2 Argentina Autoimmune Disease Diagnostics Market by Product
10.5.6.2.3 Argentina Autoimmune Disease Diagnostics Market by Technology
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PFIZER INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBOTT LABORATORIES
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BECKMAN COULTER, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INOVA DIAGNOSTICS INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIO-RAD LABORATORIES INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HEMAGEN DIAGNOSTICS INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. F. Hoffmann-La Roche
3. Novartis AG
4. Pfizer Inc.
5. Sanofi
6. Abbott Laboratories
7. Beckman Coulter, Inc.
8. Inova Diagnostics Inc.
9. Bio-Rad Laboratories Inc.
10. Hemagen Diagnostics Inc.